XTX Topco’s Medifast MED Stock Holding History

XTX Topco’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$325K	Buy	+30,654	New	+$354K	﹤0.01%	2845
2024 Q4	–	Sell	-18,184	Closed	-$348K	–	2685
2024 Q3	$348K	Buy	+18,184	New	+$350K	0.03%	1091
2023 Q3	–	Sell	-4,537	Closed	-$418K	–	1830
2023 Q2	$418K	Buy	4,537 +930	+26%	+$82.8K	0.07%	489
2023 Q1	$374K	Buy	+3,607	New	+$400K	0.08%	480
2021 Q4	–	Sell	-1,927	Closed	-$371K	–	872
2021 Q3	$371K	Buy	+1,927	New	+$474K	0.12%	282

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

XTX Topco's MED Position: Q2 2026 in Review

XTX Topco opened a new position in Medifast (MED) in Q2 2026: 30,654 shares worth $325K. The stake represents ﹤0.01% of the portfolio and ranks #2845 among its holdings. This is a return to the name: XTX Topco previously reported a position in MED as recently as Q3 2024.

XTX Topco first reported a position in MED in Q3 2021 and has held it in 5 quarters since. The position peaked at $418K in Q2 2023. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

XTX Topco held 30,654 shares of Medifast worth $325K as of Q2 2026.
Medifast was a new XTX Topco position in Q2 2026.
Medifast made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2845 holding.
XTX Topco first reported a position in Medifast in Q3 2021 and has held it in 5 quarters since.
XTX Topco's Medifast position peaked at $418K in Q2 2023.
112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.